+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 3Years +
All Genders
ID03977753

Evaluating the Effectiveness of 2LVERU JUNIOR and 2LVERU Compared to Placebo for Treating Common, Plantar, and Flat Warts

Led by Labo'Life · Updated on 2026-08-31

162

Participants Needed

6

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Human papillomavirus HPV infection is very common and often causes warts, which can appear at any age. This trial is studying the effectiveness of two treatments, 2LVERU JUNIOR and 2LVERU, compared to a placebo in helping warts disappear. It is a randomized, placebo-controlled, double-blind study aiming to evaluate the disappearance of warts at 6 months after treatment. Participants will take one capsule daily, 15-30 minutes before breakfast on an empty stomach, following a sequence of capsules numbered 1 through 10, continuing this cycle for 6 months. The study includes two groups one receiving 2LVERU JUNIOR or 2LVERU and the other receiving a placebo. After the 6-month treatment phase, participants will be followed for an additional 3 months to monitor wart recurrence. During the study, participants will visit their doctor for assessments of wart disappearance at 4 and 6 months, pain evaluation, and safety monitoring through reports of adverse events. The main outcome is the complete disappearance of warts at 6 months, judged by normal skin color, texture, and touch at the wart site. The total study duration may last up to 45 months, including 36 months of patient enrollment and 9 months of follow-up.

CONDITIONS

Brief Title

Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts

Research Team

C

Charlotte Bolle

L

Laura FERTE

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here